Intelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024INBS will ...

Intelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024 INBS will include data from recent PK study alongside results of meth ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy ...

Obi…How book project was conceived in 2018 — Fayemi By Dickson Omobola LAGOS — FORMER Commonwealth Secretary-General, Chief ...

There are plenty of short films in anime, and these are just some of the best ones out there for fans to try out.

Unlike the other media watchdogs, NewsGuard is a for-profit company, making money in a variety of ways that include licensing its rating.

On August 11, Transplant International published a review that concluded that dd-cfDNA is a valuable, non-invasive biomarker that enhances graft surveillance and personalized therapy for patients with ...

Nomination materials should address and provide specific examples of at least five of the following ... education, and engagement. A 100-word bio that includes phonetic spelling of the faculty ...

Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 for the same period one year ago. The increase is driven by the license ...

This kit is unique because it enables precise measurements, even at the crude lysate stage, and requires only a minimal sample input ... and how does Bio-Rad ensure their reliability?